![Kimberly Steinmann](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kimberly Steinmann
Direttore Tecnico/Scientifico/R&S presso CURIS, INC.
Provenienza dei contatti di primo grado di Kimberly Steinmann
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
18
| Public Company | Biotechnology | 18 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Kimberly Steinmann tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal | |
BIOGEN INC. | Pharmaceuticals: Major | Comptroller/Controller/Auditor Corporate Officer/Principal | |
Bayer Corp.
![]() Bayer Corp. Pharmaceuticals: MajorHealth Technology Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
EXELIXIS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
HUMANIGEN, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
SUTRO BIOPHARMA, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
GENOCEA BIOSCIENCES, INC. | Biotechnology | Director of Finance/CFO | |
FORMA Therapeutics, Inc.
![]() FORMA Therapeutics, Inc. BiotechnologyHealth Technology FORMA Therapeutics, Inc. discovers and develops medicines for cancer and other genetically driven diseases. Its drug discovery engine deploys screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. The company was founded by Steven Tregay, Nikolai Kley, Stuart L. Schreiber, Todd R. Golub, Michael Foley and Alexis Borisy in 2008 and is headquartered in Watertown, MA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
BioTheryX, Inc.
![]() BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
TESARO INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of Medicine & Dentistry of New Jersey | College/University | Doctorate Degree | |
MIRATI THERAPEUTICS | Biotechnology | Chief Tech/Sci/R&D Officer | |
Talon Therapeutics, Inc.
![]() Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Boston College | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
Gettysburg College | College/University | Undergraduate Degree | |
The University of Chicago | College/University | Corporate Officer/Principal | |
Northeastern University
![]() Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Graduate Degree | |
University of Illinois | College/University | Undergraduate Degree | |
University of Maryland | College/University | Undergraduate Degree | |
University of Massachusetts | College/University | Undergraduate Degree | |
Harvard Pilgrim Health Care, Inc.
![]() Harvard Pilgrim Health Care, Inc. Managed Health CareHealth Services Harvard Pilgrim Health Care, Inc. operates as a non-profit organization that provides administrative healthcare services. It offers health insurance options for companies, families, and individuals. The company was founded in 1969 and is headquartered in Wellesley, MA. | Managed Health Care | Corporate Officer/Principal | |
Robert Wood Johnson Medical School | College/University | Doctorate Degree | |
American Society of Clinical Oncology, Inc.
![]() American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal | |
Clinical Cancer Research | Corporate Officer/Principal | ||
Tufts Medical Center, Inc.
![]() Tufts Medical Center, Inc. Hospital/Nursing ManagementHealth Services Tufts Medical Center, Inc. owns and operates an academic medical center. It provides healthcare services and programs in the areas of allergy, anesthesiology, bariatric surgery, cancer, cardiology, colon and rectal, clinical nutrition, dentistry, dermatology, ENT/otolaryngology, endocrinology, diabetes and metabolism, gastroenterology, general surgery, geriatrics, hematology/oncology, hyperbaric medicine, infectious diseases, maternity, nephrology, neurology, neurosurgery, and nutrition. The firm also offers services in the areas of obstetrics and gynecology, occupational therapy, ophthalmology, orthopedics, otolaryngology, pain management, palliative care, pathology, pediatrics, physical medicine, physical therapy, plastic surgery, psychiatry, pulmonary, radiation oncology, radiology, rheumatology, speech language pathology and audiology, thoracic and transplant surgery, trauma surgery, urology, vascular surgery, wound healing, and weight and wellness. The company was founded in 1796 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
Duke University Medical Center | College/University | Corporate Officer/Principal | |
JAZZ PHARMACEUTICALS PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
DIMENSION THERAPEUTICS INC | Biotechnology | Director/Board Member | |
Yale School of Medicine | College/University | Corporate Officer/Principal | |
Stritch School of Medicine | College/University | Doctorate Degree | |
Tufts University School of Medicine | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Anokion SA
![]() Anokion SA Medical/Nursing ServicesHealth Services Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland. | Medical/Nursing Services | Chief Executive Officer | |
Kanyos Bio, Inc.
![]() Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Kanyos Bio, Inc. engages in the provision of immune tolerance technology solutions. It develops antigen-specific for treatment of type-1 diabetes and celiac disease. The company was founded by Jeffrey Hubbell, Stephan Kontos, Oscar Buset, Kristen M. Lorentz, and David A. Lowin in 2015 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Executive Officer | |
Torque Therapeutics, Inc.
![]() Torque Therapeutics, Inc. BiotechnologyHealth Technology Torque Therapeutics, Inc. develops immunotherapies to address cancers focused on the specific modulation of immune cell subsets. The company was founded by Bart Henderson, Ulrik B. Nielsen, Darrell J. Irvine, and Thomas Lars Andresen and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
EVELO BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
NEXTCURE, INC. | Pharmaceuticals: Major | Director/Board Member | |
Cygnal Therapeutics, Inc.
![]() Cygnal Therapeutics, Inc. BiotechnologyHealth Technology Cygnal Therapeutics, Inc. develops drugs for cancer, immunological diseases and regenerative processes. The company was founded by Noubar Afeyan, Avak Kahvejian and Jordi Mata-Fink in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Epi-Cure Pharmaceuticals, Inc.
![]() Epi-Cure Pharmaceuticals, Inc. BiotechnologyHealth Technology Epi-Cure Pharmaceuticals, Inc. is a private company that focuses on researching and developing pharmaceutical products. The company is based in Weston, MA. The company was founded in 2016 by Robert E. Martell. | Biotechnology | Founder | |
ARAVIVE, INC. | Biotechnology | Director/Board Member | |
NiKang Therapeutics, Inc.
![]() NiKang Therapeutics, Inc. BiotechnologyHealth Technology NiKang Therapeutics, Inc. operates as biotechnology company. It focuses on developing novel small molecule oncology drug discovery. The company was founded by Zhenhai Gao and is headquartered in Wilmington, DE. | Biotechnology | Director/Board Member | |
Trishula Therapeutics, Inc.
![]() Trishula Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trishula Therapeutics, Inc. is a company solely dedicated to developing TTX-030, a first-in-class anti-CD39 antibody aimed at improving outcomes for people with cancer. Trishula Therapeutics is based in South San Francisco, CA. The company's leadership, board of directors, scientific advisory board, investors, and partners are all committed to this goal. Anil Singhal has been the CEO of the company since 2021. | Pharmaceuticals: Major | Director/Board Member | |
ARRIVENT BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
INDAPTUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Sonata Therapeutics, Inc.
![]() Sonata Therapeutics, Inc. BiotechnologyHealth Technology Sonata Therapeutics, Inc. is a pioneering private company based in Cambridge, MA that designs single therapeutics to reprogram diseased cells and create curative microenvironments. The company's machine learning-based platform identifies novel insights, targets, and therapeutics across a wide range of disease areas, with a growing pipeline of small molecule drugs and genetic therapeutics. In oncology, Sonata's transformative therapies reprogram cancer cells to release curative signals that reverse immune cell suppression and blockade, empowering the immune system to holistically eradicate tumors and drive cure. Sonata Therapeutics is creating a new class of network medicines™ designed to modulate all the key cell types in a disease microenvironment required to drive disease resolution. The company is also exploring additional therapeutic areas such as fibrosis and tissue regeneration where multicellular networks play a key role. The company has subsidiaries in the United States. The company was founded in 2022 by flagship pioneering, and the CEO is Volker Herrmann. | Biotechnology | Director/Board Member | |
CARISMA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Kalobios Pharmaceuticals, Inc. | Corporate Officer/Principal |
Statistiche
Distribuzione geografica
Stati Uniti | 48 |
Svizzera | 3 |
Irlanda | 2 |
Settori
Health Technology | 31 |
Consumer Services | 14 |
Health Services | 5 |
Technology Services | 2 |
Posizioni
Director/Board Member | 63 |
Corporate Officer/Principal | 57 |
Chief Tech/Sci/R&D Officer | 22 |
Independent Dir/Board Member | 21 |
Undergraduate Degree | 15 |
Contatti più connessi
Insiders | |
---|---|
Lori Kunkel | 27 |
Martyn Greenacre | 19 |
John Hohneker | 19 |
Robert Martell | 18 |
Marc Rubin | 17 |
Anne Borgman | 13 |
Kenneth Kaitin | 12 |
Christine Guertin | 10 |
James Dentzer | 9 |
Jonathan Zung | 9 |
Diantha Duvall | 8 |
Felix Geissler | 7 |
Dora Ferrari | 5 |
Mark W. Noel | 5 |
Nancy Soohoo | 5 |
- Borsa valori
- Insiders
- Kimberly Steinmann
- Connessioni Società